Formalin-evoked Fos expression in spinal cord is enhanced in morphine- tolerant rats

Brain Research

Volumn 766, Issue 1-2, 1997, Pages 93-100

  Rohde, Dana S ^a   Detweiler, Dawn J ^b   Basbaum, Allan I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL SYSTEM   (United States)

Author keywords

Central sensitization; Dependence; Dorsal horn; Hyperalgesia; Morphine; Tolerance

Indexed keywords

FORMALDEHYDE; MORPHINE; OPIATE RECEPTOR; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG TOLERANCE; ETIOLOGY; GENE EXPRESSION; HYPERALGESIA; HYPERPOLARIZATION; IMMUNOCYTOCHEMISTRY; LUMBAR SPINAL CORD; MALE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SENSITIZATION; SPINAL CORD; SPINAL CORD DORSAL HORN;

ANIMALS; DRUG TOLERANCE; FORMALDEHYDE; HINDLIMB; HYPERALGESIA; MALE; MORPHINE; NARCOTICS; PAIN; PLACEBOS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD;

EID: 0030931498     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00582-9     Document Type: Article

References (52)

1. Abbott F.V., Hong Y., Franklin K.B.J. The effect of lesions of the dorsolateral funiculus on formalin pain and morphine analgesia: a dose-response analysis. Pain. 65:1996;17-23.
2. Aghajanian G.K. Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature. 276:1978;186-188.
3. Atweh S.M., Kuhar M.J. Autoradiographic localization of opiate receptors in rat brain. I. Spinal cord and lower medulla Brain Res. 124:1977;53-67.
4. Basbaum A.I., Fields H.L. Endogenous pain control mechanisms: review and hypothesis. Ann. Neurol. 4:1978;451-462.
5. Basbaum A.I., Fields H.L. Endogenous pain control systems. Annu. Rev. Neurosci. 7:1984;309-338.
6. Ben E.S., Marek P., Vaccarino A.L., Mogil J.S., Sternberg W.F., Liebeskind J.C. The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the rat. Brain Res. 575:1992;304-308.
7. Bredt D., Snyder S.H. Nitric oxide, a novel neuronal messenger. Neuron. 8:1992;3-11.
8. Christensen B.N., Perl E.R. Spinal neurons specifically excited by noxious thermal stimuli: marginal zone of the dorsal horn. J. Neurophysiol. 33:1970;293-307.
9. Christie M.H., Williams J.T., North R.A. Cellular mechanisms of opioid tolerance: studies in single brain neurons. Mol. Pharmacol. 32:1987;633-638.
10. Cook A.J., Woolf C.J., Wall P.D., McMahon S.B. Dynamic receptive field plasticity in rat spinal cord dorsal horn following C-primary afferent input. Nature. 325:1987;151-153.
11. B.M. Cox, Molecular and cellular mechanisms in opioid tolerance, in: A.I. Basbaum, J.-M. Besson (Eds.), Towards a New Pharmacotherapy of Pain, John Wiley & Sons, Chichester, UK, 1991, pp. 137-156.
12. Detweiler D.J., Rohde D.S., Basbaum A.I. The development of opioid tolerance in the formalin test in the rat. Pain. 63:1995;251-254.
13. Duman R.S., Tallman J.F., Nestler E.J. Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus. J. Pharmacol. Exp. Ther. 246:1988;1033-1039.
14. G-nitro-L-arginine, attenuate analgesic tolerance to the mu opioid morphine but not to kappa opioids. Pain. 56:1994;69-75.
15. Fitzgerald M., Wall P.D. The laminar organization of dorsal horn cells responding to peripheral C-fibre stimulation. Exp. Brain Res. 41:1980;36-44.
16. Fry J.P., Herz A., Zieglgansberger W. A demonstration of naloxone-precipitated opiate withdrawal on single neurones in the morphine-tolerant/dependent rat brain. Br. J. Pharmacol. 68:1980;585-592.
17. Gogas K.R., Cho H.J., Botchkina G.I., Levine J.D., Basbaum A.I. Inhibition of noxious stimulus-evoked pain behaviors and neuronal fos-like immunoreactivity in the spinal cord of the rat by supraspinal morphine. Pain. 65:1996;9-15.
18. Gogas K.R., Presley R.W., Levine J.D., Basbaum A.I. The antinociceptive action of supraspinal opioids results from an increase in descending inhibitory control: correlation of nociceptive behavior and c-fos expression. Neuroscience. 42:1991;617-628.
19. Griffin M.T., Law P.Y., Loh H.H. Involvement of both inhibitory and stimulating guanine nucleotide binding proteins in the expression of chronic opiate regulation of adenylyl cyclase activity in NG 108-15 cells. J. Neurochem. 45:1985;1585-1589.
20. Guilbaud G., Besson J.M., Oliveras J.L., Liebeskind J.C. Suppression by LSD of the inhibitory effect exerted by dorsal raphe stimulation on certain spinal cord interneurons in the cat. Brain Res. 61:1973;417-422.
21. Hayward M.D., Duman R.S., Nestler E.J. Induction of the c-fos proto-oncogene during opiate withdrawal in the locus coeruleus and other regions of rat brain. Brain Res. 525:1990;256-266.
22. Hsu S., Raine L., Fanger H. A comparative study of the antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am. J. Clin. Pathol. 75:1981;734-738.
23. Hylden J., Nahin R.L., Traub R.J., Dubner R. Expansion of receptive fields of spinal lamina I projection neurons in rats with unilateral adjuvant-induced inflammation: the contribution of dorsal horn mechanisms. Pain. 37:1989;229-243.
24. 3H-nitrendipine binding. Prog. Clin. Biol. Res. 328:1990;469-472.
25. Johnstone R.E., Smith D.J. Complete tolerance to opioids. Anesth. Analg. 75:1992;467.
26. Kolesnikov Y.A., Pick C.G., Ciszewska G., Pasternak G.W. Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor. Proc. Natl. Acad. Sci. USA. 90:1993;5162-5166.
27. LaMotte C., Pert C.B., Snyder S.H. Opiate receptor binding in primate spinal cord: distribution and changes after dorsal root section. Brain Res. 112:1976;407-412.
28. Light A.R., Perl E.R. Spinal termination of functionally identified primary afferent neurons with slowly conducting myelinated fibers. J. Comp. Neurol. 186:1979;133-150.
29. Llewellyn-Smith I.J., Minson J.B. Complete penetration of antibodies into vibratome sections after glutaraldehyde fixation and ethanol treatment: light and electron microscopy for neuropeptides. J. Histochem. Cytochem. 40:1992;1741-1749.
30. Makman M.H., Dvorkin B., Crain S.M. Modulation of adenylate cyclase activity of mouse spinal cord ganglion explants by opioids, serotonin and pertussis toxin. Brain Res. 445:1988;303-313.
31. Malmberg A.B., Yaksh T.L. Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats. Pain. 54:1993;291-300.
32. Mao J., Price D.D., Mayer D.J. Thermal hyperalgesia in association with the development of morphine tolerance in the rat: roles of excitatory amino acid receptors and protein kinase C. J. Neurosci. 14:1994;2301-2312.
33. Mao J., Price D.D., Mayer D.J., Hayes R.L. Pain-related increases in spinal cord membrane-bound protein kinase C following peripheral nerve injury. Brain Res. 588:1992;144-149.
34. Mao J., Price D.D., Mayer D.J., Lu J., Hayes R.L. Intrathecal MK-801 and local nerve anesthesia synergistically reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy. Brain Res. 576:1992;254-262.
35. Mayer D.J., Mao J., Price D.D. The development of morphine tolerance and dependence is associated with translocation of protein kinase C. Pain. 61:1995;365-374.
36. Meller S.T., Cummings C.P., Traub R.J., Gebhart G.F. The role of nitric oxide in the development and maintenance of the hyperalgesia produced by intraplantar injection of carrageenan in the rat. Neuroscience. 60:1994;367-374.
37. Menétrey D., Gannon A., Levine J.D., Basbaum A.I. Expression of c-fos protein in interneurons and projection neurons of the rat spinal cord in response to noxious somatic, articular and visceral stimulation. J. Comp. Neurol. 285:1989;177-195.
38. Nestler E.J. Molecular mechanisms of drug addiction. J. Neurosci. 12:1992;2439-2450.
39. Nestler E.J., Tallman J.F. Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus ceruleus. Mol. Pharmacol. 33:1988;127-132.
40. Presley R.W., Menétrey D., Levine J.D., Basbaum A.I. Systemic morphine suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in the rat spinal cord. J. Neurosci. 10:1990;323-335.
41. Rohde D.S., Detweiler D.J., A.I. B. Spinal cord fos-like immunoreactivity (FLI) during precipitated abstinence: comparison with patterns evoked by noxious stimulation. Soc. Neurosci. Abstr. 19:1993;1247.
42. Rohde D.S., Detweiler D.J., Basbaum A.I. Spinal cord mechanisms of opioid tolerance and dependence: Fos-like immunoreactivity increases in subpopulations of spinal cord neurons during withdrawal. Neuroscience. 72:1996;233-242.
43. D.S. Rohde, W.R. McKay, D.S. Chang, C. Abbadie and A.I. Basbaum, The contribution of supraspinal, peripheral and intrinsic spinal circuits to the pattern and magnitude of Fos-like immunoreactivity in the lumbar spinal cord of the rat withdrawing from morphine, Neuroscience in press.
44. Sharma S.K., Klee W.A., Nirenberg M. Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc. Natl. Acad. Sci. USA. 72:1975;3092-3096.
45. Sjögren P., Jensen N.H., T.S J. Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonists. Pain. 59:1994;313-316.
46. Sluka K.A., Willis W.D., Westlund K.N. Joint inflammation and hyperalgesia are reduced by spinal bicuculline. NeuroReport. 5:1993;109-112.
47. Tölle T.R., Castro-Lopes J.M., Coimbra A., Zieglgänsberger W. Opiates modify induction of c-fos proto-oncogene in the spinal cord of the rat following noxious stimulation. Neurosci. Lett. 111:1990;46-51.
48. Trujillo K.A., Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science. 251:1991;85-87.
49. Werling L.L., McMahon P.N., Cox B.M. Selective changes in mu receptor properties induced by chronic morphine exposure. Proc. Natl. Acad. Sci. USA. 86:1989;6393-6397.
50. Wheeler-Aceto H., Cowan A. Standardization of the rat paw formalin test for the evaluation of analgesics. Psychopharmacology. 104:1991;35-44.
51. Woolf C.J. Evidence for a central component of post-injury pain hypersensitivity. Nature. 308:1983;686-688.
52. Woolf C.J., Thompson S. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain. 44:1991;293-299.